Latest news with #CDMO
&w=3840&q=100)
Business Standard
13 hours ago
- Health
- Business Standard
Over 600 fall ill during Puri Rath Yatra, many admitted to hospitals
According to Puri Chief District Medical Officer (CDMO) Dr. Kishore Satapathy, several people reported minor injuries, vomiting, and fainting primarily due to overcrowded conditions Press Trust of India Puri Nearly 625 people fell ill and many had to be admitted to hospitals due to sweltering heat and overcrowding during Rath Yatra here on Friday, officials said. According to Puri Chief District Medical Officer (CDMO) Dr. Kishore Satapathy, several people reported minor injuries, vomiting, and fainting primarily due to overcrowded conditions. "Most of them were discharged after receiving preliminary treatment at OPDs. There were no casualties," he added. Odisha Health and Family Welfare Minister Mukesh Mahaling said the primary cause of illness among devotees was extreme heat and humid conditions. Around 70 people were undergoing treatment at the District Headquarters Hospital in Puri, with nine reported to be in critical condition, an official said. Meanwhile, sources claimed that a number of people were injured near Balagandi area where Lord Balabhadra's chariot, Taladhwaja, remained stuck for over an hour. "The prolonged halt led to a dense buildup of crowd, resulting in several people getting trapped and sustained injuries while trying to get out of the congested area," an official said. The injured were promptly shifted to hospitals with assistance of volunteers from government agencies and private organisations. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
The Print
18 hours ago
- Health
- The Print
Over 600 people fall ill during Puri Rath Yatra , many admitted to hospitals
'Most of them were discharged after receiving preliminary treatment at OPDs. There were no casualties,' he added. According to Puri Chief District Medical Officer (CDMO) Dr. Kishore Satapathy, several people reported minor injuries, vomiting, and fainting — primarily due to overcrowded conditions. Puri, Jun 27(PTI) Nearly 625 people fell ill and many had to be admitted to hospitals due to sweltering heat and overcrowding during Rath Yatra here on Friday, officials said. Odisha Health and Family Welfare Minister Mukesh Mahaling said the primary cause of illness among devotees was extreme heat and humid conditions. Around 70 people were undergoing treatment at the District Headquarters Hospital in Puri, with nine reported to be in critical condition, an official said. Meanwhile, sources claimed that a number of people were injured near Balagandi area where Lord Balabhadra's chariot, Taladhwaja, remained stuck for over an hour. 'The prolonged halt led to a dense buildup of crowd, resulting in several people getting trapped and sustained injuries while trying to get out of the congested area,' an official said. The injured were promptly shifted to hospitals with assistance of volunteers from government agencies and private organisations. PTI AAM MNB This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Business Standard
3 days ago
- Business
- Business Standard
NSE SME Influx Healthtech makes a strong debut
Shares of Influx Healthtech were trading at Rs 130 on the NSE, a premium of 35.42% compared with the issue price of Rs 96. The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public offer (IPO) price. The stock was currently down 1.9% over its listing price. The counter hit a high of Rs 135.85 and a low of Rs 125.90. About 28.55 lakh shares of the company changed hands at the counter. Influx Healthtech's IPO was subscribed 187.31 times. The issue opened for bidding on 18 June 2025 and it closed on 20 June 2025. The price band of the IPO was fixed at Rs 91 to Rs 96 per share. The IPO of 61,00,800 equity shares comprised a fresh issue of 50,00,400 equity shares and offer for sale (OFS) of 11,00,400 equity shares. The promoter and promoter group shareholding diluted to 73.53% from 99.85% pre-issue. The company intends to utilize the net proceeds for funding capital expenditure requirements for setting up of manufacturing facility for nutraceutical division, funding capital expenditure requirements for setting up of manufacturing facility for veterinary food division, purchase of machineries for homecare and cosmetic division and general corporate expenses. Ahead of the Influx Healthtech on 17 June 2025, raised Rs 16.66 crore from anchor investors. The board has allotted 17.36 lakh shares at Rs 96 per share to 8 anchor investors. Influx Healthtech is a Mumbai-based, healthcare focused company specialising in contract manufacturing. Since its inception in 2020, the company has established itself as a reliable contract development and manufacturing organization (CDMO). The company offers comprehensive production services across a wide range of categories, including dietary and nutritional supplements, cosmetics, ayurvedic and herbal products, veterinary feed supplements, homecare products, active pharmaceutical ingredients (APIs), and finished dosage forms such as tablets, capsules and injectables. The company had a total workforce of 163 permanent employees on a payroll basis. The company recorded revenue from operations of Rs 104.85 crore and net profit of Rs 13.37 crore for the period ended 31 March 2025.
Economic Times
4 days ago
- Business
- Economic Times
Influx Healthtech IPO debut today: GMP signals moderate listing buzz
As per the latest update, the grey market premium (GMP) stands at Rs 20, translating to an expected listing price of Rs 116 per share, over the IPO price of Rs 96 — a potential 20.83% gain on listing. Synopsis Influx Healthtech is set to debut on the NSE SME platform today after its Rs 58.57 crore IPO. The IPO price was fixed at Rs 96 per share. The company, a CDMO established in 2020, offers manufacturing and product development services for nutraceuticals, cosmetics, and other healthcare products, operating from facilities in Thane, Maharashtra. Healthcare-focused contract manufacturer Influx Healthtech is set to make its market debut on the NSE SME platform today. The Rs 58.57 crore IPO, which concluded its bidding on June 20, has entered the final leg of its public issue journey, with allotments wrapped up and shares ready for listing. ADVERTISEMENT As per the latest update, the grey market premium (GMP) stands at Rs 20, translating to an expected listing price of Rs 116 per share, over the IPO price of Rs 96 — a potential 20.83% gain on listing. The IPO comprised a fresh issue of 50 lakh shares worth Rs 48 crore and an offer for sale (OFS) of 11 lakh shares worth Rs 10.56 crore, offering a total of 61,00,800 shares. The IPO price was fixed at Rs 96 per share. The anchor portion attracted Rs 16.67 crore, with shares allocated to institutional investors a day before the issue in 2020, Influx Healthtech is a CDMO (Contract Development and Manufacturing Organization) providing end-to-end manufacturing and product development services for nutraceuticals, cosmetics, personal care, ayurvedic, veterinary, and homecare products. ADVERTISEMENT Operating out of three modern facilities in Thane, Maharashtra, the company boasts an extensive portfolio including gummies, capsules, powders, skincare products, herbal supplements, and veterinary feed formulations. It serves nutraceutical, cosmetic, and healthcare clients, handling everything from formulation and R&D to regulatory support and company currently employs 163 people and continues to expand its product capabilities and client reach, focusing on innovation and scalability in fast-growing consumer health segments. ADVERTISEMENT Influx Healthtech posted a revenue of Rs 104.99 crore in FY25, up 5% year-on-year, while PAT rose 19% to Rs 13.37 crore. It maintains a robust ROE of 36.98%, EBITDA margin of 19.62%, and negligible debt. ADVERTISEMENT (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel) Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains NEXT STORY
Time of India
4 days ago
- Business
- Time of India
Influx Healthtech IPO debut today: GMP signals moderate listing buzz
Healthcare-focused contract manufacturer Influx Healthtech is set to make its market debut on the NSE SME platform today. The Rs 58.57 crore IPO, which concluded its bidding on June 20, has entered the final leg of its public issue journey, with allotments wrapped up and shares ready for listing. As per the latest update, the grey market premium (GMP) stands at Rs 20, translating to an expected listing price of Rs 116 per share, over the IPO price of Rs 96 — a potential 20.83% gain on listing. IPO Overview The IPO comprised a fresh issue of 50 lakh shares worth Rs 48 crore and an offer for sale (OFS) of 11 lakh shares worth Rs 10.56 crore, offering a total of 61,00,800 shares. The IPO price was fixed at Rs 96 per share. The anchor portion attracted Rs 16.67 crore, with shares allocated to institutional investors a day before the issue opened. Company background Established in 2020, Influx Healthtech is a CDMO (Contract Development and Manufacturing Organization) providing end-to-end manufacturing and product development services for nutraceuticals, cosmetics, personal care, ayurvedic, veterinary, and homecare products. Operating out of three modern facilities in Thane, Maharashtra, the company boasts an extensive portfolio including gummies, capsules, powders, skincare products, herbal supplements, and veterinary feed formulations. It serves nutraceutical, cosmetic, and healthcare clients, handling everything from formulation and R&D to regulatory support and packaging. The company currently employs 163 people and continues to expand its product capabilities and client reach, focusing on innovation and scalability in fast-growing consumer health segments. Financials and Valuation Influx Healthtech posted a revenue of Rs 104.99 crore in FY25, up 5% year-on-year, while PAT rose 19% to Rs 13.37 crore. It maintains a robust ROE of 36.98%, EBITDA margin of 19.62%, and negligible debt. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
